Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Polivka

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Journal of Neuropathology and Experimental Neurology|January 7, 2016
Prognostic and Therapeutic Markers in Chordomas: A Study of 287 TumorsArnault Tauziéde-Espariat, Damien Bresson, Marc Polivka, et al.
Human Mutation|September 27, 2021
A bi-allelic loss-of-function SARS1 variant in children with neurodevelopmental delay, deafness, cardiomyopathy, and decompensation during feverJean-Marie Ravel, Natacha Dreumont, Pauline Mosca, et al.
Journal of Neuropathology and Experimental Neurology|January 24, 2018
Pediatric Chordomas: Results of a Multicentric Study of 40 Children and Proposal for a Histopathological Prognostic Grading System and New Therapeutic StrategiesKévin Beccaria, Arnault Tauziède-Espariat, Franck Monnien, et al.
Neuro-Oncology|February 13, 2018
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphomaAurélie Bruno, Karim Labreche, Maïlys Daniau, et al.
Nature Communications|June 20, 2018
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomasShai Rosenberg, Iva Simeonova, Franck Bielle, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomasAlberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, et al.
Neuro-Oncology|February 7, 2020
High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterpartsAlexandre Roux, Johan Pallud, Raphaël Saffroy, et al.
Neuro-Oncology|September 11, 2019
Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomasAurore Surun, Pascale Varlet, Laurence Brugières, et al.
Acta Neuropathologica Communications|June 1, 2022
The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profileArnault Tauziède-Espariat, Thibaut Pierre, Michel Wassef, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Journal of Neuropathology and Experimental Neurology|January 7, 2016
Prognostic and Therapeutic Markers in Chordomas: A Study of 287 TumorsArnault Tauziéde-Espariat, Damien Bresson, Marc Polivka, et al.
Human Mutation|September 27, 2021
A bi-allelic loss-of-function SARS1 variant in children with neurodevelopmental delay, deafness, cardiomyopathy, and decompensation during feverJean-Marie Ravel, Natacha Dreumont, Pauline Mosca, et al.
Journal of Neuropathology and Experimental Neurology|January 24, 2018
Pediatric Chordomas: Results of a Multicentric Study of 40 Children and Proposal for a Histopathological Prognostic Grading System and New Therapeutic StrategiesKévin Beccaria, Arnault Tauziède-Espariat, Franck Monnien, et al.
Neuro-Oncology|February 13, 2018
Identification of novel recurrent ETV6-IgH fusions in primary central nervous system lymphomaAurélie Bruno, Karim Labreche, Maïlys Daniau, et al.
Nature Communications|June 20, 2018
A recurrent point mutation in PRKCA is a hallmark of chordoid gliomasShai Rosenberg, Iva Simeonova, Franck Bielle, et al.
Brain Pathology (Zurich, Switzerland)|July 27, 2021
An integrative histopathological and epigenetic characterization of primary intracranial mesenchymal tumors, FET:CREB-fused broadening the spectrum of tumor entities in comparison with their soft tissue counterpartsArnault Tauziède-Espariat, Philipp Sievers, Frédérique Larousserie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2012
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomasAlberto Gonzalez-Aguilar, Ahmed Idbaih, Blandine Boisselier, et al.
Neuro-Oncology|February 7, 2020
High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterpartsAlexandre Roux, Johan Pallud, Raphaël Saffroy, et al.
Neuro-Oncology|September 11, 2019
Medulloblastomas associated with an APC germline pathogenic variant share the good prognosis of CTNNB1-mutated medulloblastomasAurore Surun, Pascale Varlet, Laurence Brugières, et al.
Acta Neuropathologica Communications|June 1, 2022
The dural angioleiomyoma harbors frequent GJA4 mutation and a distinct DNA methylation profileArnault Tauziède-Espariat, Thibaut Pierre, Michel Wassef, et al.
Pageof 10